492 Chemotherapy and bevacizumab combinations in second-line or more for metastatic breast cancer: efficacy and toxicity results
A. Fillette, C. Guerin, I. Debrix, F. Selle, M. Ontkova, K. Beerblock, D. Avenin, A. Esteso, J.P. Lotz, J. GligorovVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)70513-9
File:
PDF, 45 KB
english, 2010